Journal list menu
Export Citations
Download PDFs
Diabetic Neuropathy
Prefrontal cortex brain damage and glycemic control in patients with type 2 diabetes
2型糖尿病患者前额叶皮质脑损伤与血糖控制
- First Published: 30 December 2019
Does undiagnosed diabetes mitigate the association between diabetes and cognitive impairment? Findings from the ELSI-Brazil study
未诊断的糖尿病是否减轻了糖尿病和认知损害之间的关联?巴西ELSI研究的结果
- First Published: 01 June 2020

Highlights
- Type 2 diabetes mellitus is associated with impaired memory but not with verbal fluency.
- The association between diabetes and impaired memory becomes not significant by combining undiagnosed and nondiabetics in the same category.
- Including undiagnosed diabetics and diabetics in the same category attenuates the association between diabetes and impaired memory.
Higher ratio of extracellular water to total body water was associated with reduced cognitive function in type 2 diabetes
2型糖尿病患者较高的细胞外水分/全身水分比值与认知功能下降有关
- First Published: 12 August 2020
The silent occurrence of cerebral small vessel disease in nonelderly patients with type 2 diabetes mellitus
2型糖尿病非老年患者中隐匿性发展的脑小血管疾病
- First Published: 09 February 2021

Highlights
- The prevalence of small vessel disease increased in young and middle-aged patients with type 2 diabetes without obvious cognitive impairment.
- The presence and severity of small vessel disease and diabetic peripheral sensorimotor polyneuropathy are independently associated.
- Our findings indicated that screening and preventive strategies targeting cognition might be considered to be moved forward in patients with type 2 diabetes, especially for those with diabetic peripheral sensorimotor polyneuropathy.
Associations between general and abdominal obesity and incident diabetic neuropathy in participants with type 2 diabetes mellitus
2型糖尿病患者全身性肥胖和腹部肥胖与新发糖尿病神经病变的相关性研究
- First Published: 05 June 2020

Highlights
- The present study found that abdominal obesity, defined by waist circumference, was associated with an increased risk of incident diabetic neuropathy in patients with type 2 diabetes mellitus, for both men and women.
- These findings extend the knowledge on the sex-specific association between abdominal obesity and diabetic neuropathy among diabetic patients, which highlights the need for further studies to elucidate the mechanism underlying sex differences in the association between waist circumference and the risk of diabetic neuropathy.
Electrophysiologically verified effects of acupuncture on diabetic peripheral neuropathy in type 2 diabetes: The randomized, partially double-blinded, controlled ACUDIN trial
电生理验证针灸对2型糖尿病周围神经病变的影响:随机、部分双盲的ACUDIN对照试验
- First Published: 04 November 2020

Highlights The ACUDIN (ACUpuncture and laser acupuncture for treatment of DIabetic peripheral Neuropathy) trial showed significant effects of acupuncture compared with placebo on type 2 diabetes-induced DPN, as measured by NCS. Improvement in the primary outcome variable sural SNAP amplitude indicates structural neuroregeneration following acupuncture. Our findings are evidence that acupuncture is an appropriate safe, nonpharmacological complementary treatment option for type 2 diabetic patients with DPN.
A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy
度洛西汀与加巴喷丁治疗痛性糖尿病神经病变的随机对照试验
- First Published: 19 December 2020

Highlights
- There is significant decrease in pain score and symptom score like diabetic neuropathy symptoms, diabetic neuropathy examination, and neuropathic disability score with duloxetine and gabapentin.
- Equivalence of duloxetine with gabapentin was established with regard to Visual Analogue Scale (VAS) scores.
- Meta-analysis of studies showed comparable efficacy of duloxetine vs gabapentin in terms of VAS scores.
Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial
低剂量纳曲酮治疗疼痛性糖尿病神经病变的疗效和安全性:一项随机、双盲、主动对照、交叉临床试验
- First Published: 20 May 2021

Highlights
- The efficacy of the opioid receptor antagonist naltrexone (2-4 mg daily, peroral) was compared with amitriptyline in people with painful diabetic neuropathy in a randomized crossover trial.
- Low-dose naltrexone showed comparable efficacy but a greater safety and tolerability profile, suggesting its future evaluation in this chronic debilitating condition.